"AZ Delta is een ziekenhuis met campussen in Rumbeke, Roeselare, Menen en Torhout. In Menen en Torhout is een goed uitgebouwde basiszorg aanwezig. Voor meer gespecialiseerde behandelingen en ingrepen wordt doorverwezen naar de hoofdcampus in Rumbeke."

During the past decade, AZ Delta (Campus Rumbeke) conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 5 clinical trials were completed, i.e. on average, 29.4% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 2 clinical trials were completed. i.e. 18.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "AZ Delta (Campus Rumbeke)" #1 sponsor was "Hoffmann-La Roche" with 12 trials, followed by "Amgen" with 3 trials sponsored, "Idorsia Pharmaceuticals Ltd." with 1 trials sponsored, "Inventiva Pharma" with 1 trials sponsored and "Swedish Orphan Biovitrum" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "AZ Delta (Campus Rumbeke)" #1 collaborator was "AbbVie" with 1 trials as a collaborator, "BioMérieux" with 1 trials as a collaborator, "Cytel Inc." with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator and "PRA Health Sciences" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "AZ Delta (Campus Rumbeke)" are "Small Cell Lung Cancer" (2 trials), "Acute Myocardial Infarction" (1 trials), "Bladder Cancer" (1 trials), "Carcinoma, Hepatocellular" (1 trials) and "Chronic Lymphocytic Leukemia" (1 trials). Many other conditions were trialed in "AZ Delta (Campus Rumbeke)" in a lesser frequency.

Most popular intervention types in "AZ Delta (Campus Rumbeke)" are "Drug" (17 trials), "Other" (2 trials), "Combination Product" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (8 trials), "Placebo" (6 trials), "Bevacizumab" (2 trials), "Carboplatin" (2 trials) and "Cobimetinib" (2 trials). Other intervention names were less common.

The vast majority of trials in "AZ Delta (Campus Rumbeke)" are 19 trials for "All" genders.

Currently, there are NaN active trials in "AZ Delta (Campus Rumbeke)". undefined are not yet recruiting, 6 are recruiting, 6 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 4 completed trials in AZ Delta (Campus Rumbeke), undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in AZ Delta (Campus Rumbeke), 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".